OBX

Obsidian Therapeutics, Inc.

Healthcare · Biotechnology

13.30$ -3.0% vs. previous close Closing price · As of: Oct 1, 2026

Statements

Income Statement

Income Statement Balance Sheet Cash Flow Ratios

Annual Quarterly

Amounts Change % Common size % Per share

Last 12 Full history

Download as CSV

All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.

Tick rows to compare them in a chart (up to 4)

Income Statement OBX
Line item	Q1 25	Q1 26
Revenue	–	–
Research & Development	–	-25.5%
Selling, General & Administrative	–	-17.0%
Total Operating Expenses	–	-23.8%
Operating Income	–	–
Pre-Tax Income	–	–
Net Income	–	–
EBITDA	–	–

Data as of: October 1, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.